Morgan Stanley’s Rein Therapeutics RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.61K | Hold |
|
|||||
|
2024
Q4 | $9.89K | Sell |
|
|||||
|
2024
Q3 | $19.6K | Buy |
|
|||||
|
2024
Q2 | $3.46K | Hold |
|
|||||
|
2024
Q1 | $8.29K | Sell |
|
|||||
|
2023
Q4 | $7.62K | Buy |
|
|||||
|
2023
Q3 | $1.9K | Hold |
|
|||||
|
2023
Q2 | $2.24K | Hold |
|
|||||
|
2023
Q1 | $1.55K | Hold |
|
|||||
|
2022
Q4 | $2.96K | Sell |
|
|||||
|
2022
Q3 | $5K | Buy |
|
|||||
|
2022
Q2 | $7K | Sell |
|
|||||
|
2022
Q1 | $15K | Sell |
|
|||||
|
2021
Q4 | $393K | Buy |
|
|||||
|
2021
Q3 | $50K | Buy |
|
|||||
|
2021
Q2 | $47K | Buy |
|
|||||
|
2021
Q1 | $17K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $21K | Sell |
|
|||||
|
2019
Q1 | $776K | Buy |
|
|||||
|
2018
Q4 | $325K | Sell |
|
|||||
|
2018
Q3 | $1.18M | Buy |
|
|||||
|
2018
Q2 | $114K | Buy |
|
|||||
|
2018
Q1 | $144K | Buy |
|
|||||
|
2017
Q4 | $86K | Buy |
|
|||||
|
2017
Q3 | $86K | Buy |
|